The recall adds to mounting FDA scrutiny of compounded GLP-1 products and could generate consumer injury and product-liability inquiries alongside other compounding-related litigation.
A recall of this scale covering widely distributed ready-to-eat meat products can generate foodborne-illness complaints and product-liability inquiries that plaintiff firms track alongside other large food-safety recalls.
Keeping a major pharmacy benefit manager in the opioid MDL bellwether pool preserves a litigation track that could shape settlement values for thousands of other PBM-related opioid claims.
Quality-control recalls of widely sold over-the-counter drugs can generate consumer complaints and potential product-liability inquiries that plaintiff firms track alongside the broader acetaminophen litigation landscape.
The verdict will be the second data point on infection-based claims in a docket of roughly 4,100 pending PowerPort cases and will further inform how both sides value remaining claims.
The new MDLs give plaintiffs centralized venues to pursue claims against two more spinal cord stimulator manufacturers, expanding litigation the firm already tracks alongside the Boston Scientific docket.
A pre-trial settlement in the third bellwether removes another test case from the jury pool in an MDL with roughly 4,000 pending claims, a development plaintiff firms track when valuing remaining cases.
The conference marks the formal start of coordinated pretrial proceedings and signals the litigation's transition from early filings toward structured discovery and eventual bellwether scheduling.
If the Panel grants the motions, manufacturer-specific spinal cord stimulator MDLs would sit alongside the Boston Scientific MDL created in June 2026.
Bellwether verdicts inform, but do not decide, the roughly 3,700 other cases pending in the MDL, and post-trial motions or an appeal may follow.
The settlement resolves claims by the participating states; claims by individual plaintiffs and school districts in the MDL remain pending.
Turnout gear claims that do not involve AFFF exposure now proceed on their own track rather than inside the AFFF litigation.
Whether participation reaches the 95% threshold will determine whether most claims in the largest pending MDL settle or continue in litigation.
Failure-to-warn claims are central to many pending Roundup cases; how the ruling applies to claims that do not depend on the label will be decided case by case.
Under Case Management Order No. 14, settlement registration runs through November 30, 2026, and the court set an initial bellwether trial for December 7, 2026, subject to its rulings on preemption and expert evidence.
Federal Boston Scientific stimulator injury cases now proceed before one judge; the Panel reported 29 actions pending as of September 1, 2026.
Pretrial proceedings for federal Dupixent cases now run before one judge; the Panel reported 35 actions pending as of September 1, 2026.
Many class actions begin with one person who noticed a pattern. Reviewing your information costs nothing and creates no obligation.
